{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:31:51Z","timestamp":1791498711743,"version":"4.3.4"},"reference-count":88,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PNRR\/2022\/C9\/MCID\/I8-Development of a program to attract highly specialized human resources from abroad in research, development, and innovation activities","award":["760252\/28.12.2023"],"award-info":[{"award-number":["760252\/28.12.2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The intricate interplay of direct and indirect mechanisms relating to immune dysfunction, chronic inflammation, and viral proteins represents a key factor of lymphomagenesis in HIV-infected patients. Indirect mechanisms based on cytokine dysregulation, HIV-induced immune dysfunction, and co-infections with oncogenic viruses induce chronic B-cell activation and generation of a prone environment for malignant transformation and tumor growth. Direct mechanisms arise from oncogenic influences of p17, Tat, and Nef HIV proteins, which generate genomic instability, alteration of cellular signaling, and activation of oncogenic pathways. Vp17\u2019s implication in lymphomagenesis and angiogenesis, ensured by activation of PAR1\/EGFR\/PI3K\/Akt and MEK\/ERK1\/2 pathways, emphasizes the critical need for developing therapeutic strategies that target their signaling mechanisms. This review shows an insight into the pathological mechanisms involved in lymphomagenesis in HIV-infected individuals, focusing on finding novel therapeutic approaches directed at immune rehabilitation and oncogenic signaling pathways.<\/jats:p>","DOI":"10.3390\/cells14100705","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:26:48Z","timestamp":1747128408000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pathological Mechanisms Involved in HIV-Associated Lymphomagenesis: Novel Targeted Therapeutic Approaches"],"prefix":"10.3390","volume":"14","author":[{"given":"Mihaela","family":"Straista","sequence":"first","affiliation":[{"name":"Centre for Advanced Medical and Pharmaceutical Research, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1923-9033","authenticated-orcid":false,"given":"Francesca","family":"Caccuri","sequence":"additional","affiliation":[{"name":"Centre for Advanced Medical and Pharmaceutical Research, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania"},{"name":"Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8150-156X","authenticated-orcid":false,"given":"Nicoleta","family":"Arnaut","sequence":"additional","affiliation":[{"name":"Centre for Advanced Medical and Pharmaceutical Research, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Caruso","sequence":"additional","affiliation":[{"name":"Centre for Advanced Medical and Pharmaceutical Research, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania"},{"name":"Section of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3767-4861","authenticated-orcid":false,"given":"Mark","family":"Slevin","sequence":"additional","affiliation":[{"name":"Centre for Advanced Medical and Pharmaceutical Research, \u201cGeorge Emil Palade\u201d University of Medicine, Pharmacy, Science and Technology, 540142 Targu Mures, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJMra1615896","article-title":"HIV-Associated Cancers and Related Diseases","volume":"378","author":"Yarchoan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epi-demiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","article-title":"Cumulative Incidence of Cancer Among Individuals with Acquired Immunodeficiency Syndrome in the United States","volume":"117","author":"Simard","year":"2011","journal-title":"Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.annonc.2024.06.003","article-title":"Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Bower","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.3390\/cimb46090596","article-title":"Immune Characteristics and Immunotherapy of HIV-Associated Lymphoma","volume":"46","author":"Liu","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/COH.0000000000000234","article-title":"Microbial translocation and microbiome dysbiosis in HIV-associated immune activation","volume":"11","author":"Zevin","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/mi.2014.107","article-title":"Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals","volume":"8","author":"Latorre","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/QAD.0000000000001771","article-title":"A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma","volume":"32","author":"Epeldegui","year":"2018","journal-title":"AIDS"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1172\/JCI45157","article-title":"Cumulative mechanisms of lymphoid tissue fibrosis and t cell depletion in HIV-1 and SIV infections","volume":"121","author":"Zeng","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Vaughan, J., Patel, M., Suchard, M., Gededzha, M., Ranchod, H., Howard, W., Snyman, T., and Wiggill, T. (2024). Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: The frequency and prognostic impact. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1340096"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Bandera, A., Ferrario, G., Saresella, M., Marventano, I., Soria, A., Zanini, F., Sabbatini, F., Airoldi, M., Marchetti, G., and Franzetti, F. (2010). CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010788"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"DeVoeght, A., Martens, H., Renard, C., Vaira, D., Debruche, M., Simonet, J., Geenen, V., Moutschen, M., and Darcis, G. (2017). Exploring the link between innate immune activation and thymic function by measuring scd14 and trecs in hiv patients living in belgium. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185761"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"pky082","DOI":"10.1093\/jncics\/pky082","article-title":"Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies","volume":"2","author":"Makgoeng","year":"2018","journal-title":"JNCI Cancer Spectr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/rmv.1850","article-title":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV","volume":"25","author":"Wang","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s12026-024-09537-x","article-title":"Tumour-associated macrophages in diffuse large B-cell lymphoma: The prognostic and therapeutic impact in a South African centre with high HIV seroprevalence","volume":"72","author":"Vaughan","year":"2024","journal-title":"Immunol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Adu-Gyamfi, C.G., Savulescu, D., George, J.A., and Suchard, M.S. (2019). Indoleamine 2, 3-Dioxygenase-Mediated Tryptophan Catabolism: A Leading Star or Supporting Act in the Tuberculosis and HIV Pas-de-Deux?. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00372"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Plan\u00e8s, R., and Bahraoui, E. (2013). HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: Effect on T cells proliferation. PLoS ONE, 8.","DOI":"10.1371\/annotation\/d333f74d-496e-48e7-ac30-6dcfdbd7a25b"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"32ra36","DOI":"10.1126\/scitranslmed.3000632","article-title":"Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease","volume":"2","author":"Favre","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"91914","DOI":"10.18632\/oncotarget.20166","article-title":"The IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells","volume":"8","author":"Lewis","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37762","DOI":"10.18632\/oncotarget.9326","article-title":"The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells","volume":"7","author":"Jochems","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Zhou, Y., Lu, J., Chen, Y.F., Hu, H.Y., Xu, X.Q., and Fu, G.F. (2021). Changes in NK Cell Subsets and Receptor Expressions in HIV-1 Infected Chronic Patients and HIV Controllers. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.792775"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Harwood, O., and O\u2019Connor, S. (2021). Therapeutic Potential of IL-15 and N-803 in HIV\/SIV Infection. Viruses, 13.","DOI":"10.3390\/v13091750"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2217\/imt-2021-0247","article-title":"Pathologically complete remission to combination of invariant NK T cells and anti-CD20 an-tibody in a refractory HIV+ diffuse large B-cell lymphoma patient","volume":"14","author":"Wang","year":"2022","journal-title":"Immunotherapy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.seminhematol.2022.11.002","article-title":"The role of viruses in HIV-associated lymphomas","volume":"59","author":"Lurain","year":"2022","journal-title":"Semin. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.78.4.1800-1816.2004","article-title":"Nuclear Factor kb-Dependent Activation of the Antiapoptotic Bfl-1 Gene by the Epstein-Barr Virus Latent Membrane Protein 1 and Activated Cd40 Receptor","volume":"78","author":"Edelstein","year":"2004","journal-title":"J. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.tranon.2019.02.009","article-title":"LMP1 and 2A Induce the Expression of Nrf2 Through Akt Signaling Pathway in Epstein-Barr Virus\u2013Transformed B Cells","volume":"12","author":"Yun","year":"2019","journal-title":"Transl. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.18632\/oncotarget.14243","article-title":"Epstein-Barr Virus Ebna2 Directs Doxorubicin Resistance of B Cell Lymphoma Through CCL3 and CCL4-mediated Activation of NF-kb andBtk","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41579-024-01010-8","article-title":"Immune targeting of HIV-1 reservoir cells: A path to elimination strategies and cure","volume":"22","author":"Bone","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-021-01134-x","article-title":"Targeting the tumor microenvironment in B-cell lymphoma: Challenges and opportunities","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lazarova, M., and Steinle, A. (2019). Impairment of NKG2D-Mediated Tumor Immunity by TGF-\u03b2. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02689"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1182\/bloodadvances.2023012116","article-title":"HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lym-phoma","volume":"8","author":"Chantziou","year":"2024","journal-title":"Blood Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00262-020-02708-3","article-title":"Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas","volume":"70","author":"Landsburg","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12981-018-0194-y","article-title":"Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells","volume":"15","author":"Nabatanzi","year":"2018","journal-title":"AIDS Res. Ther."},{"key":"ref_36","unstructured":"IARC (2012). Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1158\/1055-9965.EPI-13-0714","article-title":"Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV associated non-Hodgkin B-cell lymphoma risk","volume":"23","author":"Vendrame","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2015-11-681411","article-title":"A lymphomagenic role for HIV beyond immune suppression?","volume":"127","author":"Dolcetti","year":"2016","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Doyon-Lalibert\u00e9, K., Aranguren, M., Byrns, M., Chagnon-Choquet, J., Paniconi, M., Routy, J.P., Tremblay, C., Quintal, M.C., Brassard, N., and Kaufmann, D.E. (2022). Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2022.08.15.504021"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Odagiu, L., May, J., Boulet, S., Baldwin, T.A., and Labrecque, N. (2021). Role of the Orphan Nuclear Receptor NR4A Family in T-Cell Biology. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.624122"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1128\/JVI.02542-06","article-title":"Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD41 T cells","volume":"81","author":"Martin","year":"2007","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-065X.2010.00932.x","article-title":"Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1","volume":"237","author":"Graham","year":"2010","journal-title":"Immunol. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of Multiple Proto-Oncogenes in B-cell Diffuse Large-Cell Lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.molcel.2009.11.007","article-title":"AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations","volume":"36","author":"Robbiani","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood.V96.3.808","article-title":"The Role of Immunoglobulin Translocations in the Pathogenesis of B-cell Malignancies","volume":"96","author":"Willis","year":"2000","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/bjh.14011","article-title":"Molecular Genetics of Childhood, Adolescent and Young Adult non-Hodgkin Lymphoma","volume":"173","author":"Miles","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7166","DOI":"10.1073\/pnas.81.22.7166","article-title":"A 14;18 and an 8;14 Chromosome Translocation in a Cell Line Derived From an Acute B-Cell Leukemia","volume":"81","author":"Pegoraro","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1073\/pnas.90.11.5262","article-title":"Identification of the Gene Associated With the Recurring Chromosomal Translocations T(3;14)(q27;q32) and T(3;22)(q27;q11) in B-cell Lymphomas","volume":"90","author":"Baron","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations Involving C-Myc and C-Myc Function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-Cell Activation and Immunoregulation in Patients With the Acquired Immunodeficiency Syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"de Carvalho, P.S., Leal, F.E., and Soares, M.A. (2021). Clinical and Molecular Properties of Human Immunodeficiency Virus-Related Diffuse Large B-Cell Lymphoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.675353"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.4049\/jimmunol.170.12.5965","article-title":"Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function","volume":"170","author":"Malaspina","year":"2003","journal-title":"J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/10428194.2021.2023741","article-title":"CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus","volume":"63","author":"Hybel","year":"2022","journal-title":"Leuk. Lymphoma"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/clim.1999.4760","article-title":"The development of AIDS-associated Burkitt\u2019s\/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6","volume":"92","author":"Breen","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11684-017-0592-x","article-title":"Irreversible Phenotypic Perturbation and Functional Impairment of B Cells During Hiv-1 Infection","volume":"11","author":"Yan","year":"2017","journal-title":"Front. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1126\/science.7690497","article-title":"Immunoglobulin VH3 Gene Products: Natural Ligands for HIV Gp120","volume":"261","author":"Berberian","year":"1993","journal-title":"Science"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.4049\/jimmunol.176.7.3931","article-title":"Hiv-1 Envelope Triggers Polyclonal Ig Class Switch Recombination Through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors","volume":"176","author":"He","year":"2006","journal-title":"J. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.192.5.637","article-title":"B Cells of HIV-1-infected Patients Bind Virions Through CD21-Complement Interactions and Transmit Infectious Virus to Activated T Cells","volume":"192","author":"Moir","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/sji.12339","article-title":"Cd21-\/Low B Cells: A Snapshot of a Unique B Cell Subset in Health and Disease","volume":"82","author":"Thorarinsdottir","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Isaguliants, M., Bayurova, E., Avdoshina, D., Kondrashova, A., Chiodi, F., and Palefsky, J.M. (2021). Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers, 13.","DOI":"10.3390\/cancers13020305"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI119869","article-title":"B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues","volume":"100","author":"Frank","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bugatti, A., Caccuri, F., Filippini, F., Ravelli, C., and Caruso, A. (2021). Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants. J. Biol. Chem., 297.","DOI":"10.1016\/j.jbc.2021.100934"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1038\/s41467-023-42994-w","article-title":"HIV-1 Gag targeting to the plasma membrane reorganizes sphingomyelin-rich and cholesterol-rich lipid domains","volume":"14","author":"Tomishige","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Caccuri, F., Iaria, M.L., Campilongo, F., Varney, K., Rossi, A., Mitola, S., Schiarea, S., Bugatti, A., Mazzuca, P., and Giagulli, C. (2016). Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17. Sci. Rep., 6.","DOI":"10.1038\/srep38027"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41417-020-00246-9","article-title":"B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation","volume":"28","author":"Giagulli","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jgm.336","article-title":"Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene","volume":"5","author":"Tewari","year":"2003","journal-title":"J. Gene Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/cmdc.201200577","article-title":"Identification of a small-molecule inhibitor of HIV-1 assembly that targets the phosphatidylinositol (4,5)-bisphosphate binding site of the HIV-1 matrix protein","volume":"8","author":"Zenter","year":"2013","journal-title":"ChemMedChem"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"951724","DOI":"10.1155\/2012\/951724","article-title":"Akt: A double-edged sword in cell proliferation and genome stability","volume":"2012","author":"Xu","year":"2012","journal-title":"J. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0960-9822(02)00843-6","article-title":"A role for PI 3-kinase and PKB activity in the G2\/M phase of the cell cycle","volume":"12","author":"Shtivelman","year":"2002","journal-title":"Curr. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.humpath.2005.06.014","article-title":"Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma","volume":"36","author":"Liu","year":"2005","journal-title":"Hum. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bbapap.2005.07.030","article-title":"Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: From diabetes, obesity to cell cycle, and cancer","volume":"1754","author":"Dube","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncb814","article-title":"Nucleophosmin regulates the stability and transcriptional activity of p53","volume":"4","author":"Colombo","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/mc.10096","article-title":"Association of JNK1 with p21waf1 and p53: Modulation of JNK1 activity","volume":"36","author":"Xue","year":"2003","journal-title":"Mol. Carcinog."},{"key":"ref_74","first-page":"839","article-title":"The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3\u2019 kinase pathway","volume":"12","author":"Sattler","year":"1996","journal-title":"Oncogene"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1053\/j.gastro.2014.08.032","article-title":"PI3K regulation of RAC1 is required for KRAS-induced pancreatic tumorigenesis in mice","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1158\/1541-7786.MCR-05-0121","article-title":"p53-independent reg ulation of p21Waf1\/Cip1 expression and senescence by Chk2","volume":"3","author":"Dendouga","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1158\/1078-0432.CCR-11-3264","article-title":"Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4\/cdk6","volume":"18","author":"Tang","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1128\/MCB.18.11.6795","article-title":"Direct interaction of Jak1 and v-Abl is required for v-Abl induced activation of STATs and proliferation","volume":"18","author":"Danial","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"D\u2019Ursi, P., Rondina, A., Zani, A., Uggeri, M., Messali, S., Caruso, A., and Caccuri, F. (2024). Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants. Viruses, 16.","DOI":"10.3390\/v16071048"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/ATVBAHA.113.302478","article-title":"HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1\/endothelin B receptor axis","volume":"34","author":"Caccuri","year":"2014","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Giagulli, C., Marsico, S., Magiera, A.K., Bruno, R., Caccuri, F., Barone, I., Fiorentini, S., And\u00f2, S., and Caruso, A. (2011). Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017831"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.vaccine.2013.12.051","article-title":"Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study","volume":"32","author":"Iaria","year":"2014","journal-title":"Vaccine"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1179\/1528433614Z.0000000018","article-title":"Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope","volume":"16","author":"Iaria","year":"2015","journal-title":"HIV Clin. Trials"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Alves de Souza Rios, L., Mapekula, L., Mdletshe, N., Chetty, D., and Mowla, S. (2021). HIV-1 Transactivator of Transcription (Tat) Co-operates with AP-1 Factors to Enhance c-MYC Transcription. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.693706"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e13986","DOI":"10.7717\/peerj.13986","article-title":"Ectopic expression of HIV-1 Tat modifies gene expression in cultured B cells: Implications for the development of B-cell lymphomas in HIV-1-infected patients","volume":"10","author":"Valyaeva","year":"2022","journal-title":"PeerJ"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/leu.2017.106","article-title":"HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells","volume":"31","author":"Germini","year":"2017","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Akbay, B., Germini, D., Bissenbaev, A.K., Musinova, Y.R., Sheval, E.V., Vassetzky, Y., and Dokudovskaya, S. (2021). HIV-1 Tat Activates Akt\/mTORC1Pathway and AICDAExpression by Downregulating Its Transcriptional Inhibitors in B Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041588"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13027-020-00320-9","article-title":"HIV Nef enhances the expression of oncogenic c-MYC and activation-induced cytidine deaminase in Burkitt lymphoma cells, promoting genomic instability","volume":"15","author":"Mdletshe","year":"2020","journal-title":"Infect. Agents Cancer"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/10\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:31:49Z","timestamp":1760031109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/10\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":88,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["cells14100705"],"URL":"https:\/\/doi.org\/10.3390\/cells14100705","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]}}}